Esophageal complications of catheter ablation for atrial fibrillation: A case report  by Podgaetz, Eitan & Deschamps, Claude
Case Reportsstatus.4 Determination of the exact timing, however, re-
mains difficult. Monitoring of PAP, pulmonary capillary
wedge pressure, and LV function before and during the
weaning process is mandatory.4
We report the case of a young man with idiopathic pul-
monary arterial hypertension who underwent urgent BLTx
for decompensation. We attribute his complicated postoper-
ative course to diastolic dysfunction in a chronically de-
prived LV in combination with an increased preload,
resulting from normalization of the PVR, and an increased
afterload during weaning. Awareness of this problem may
lead to earlier discrimination of such patients and a more
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A case reportEitan Podgaetz, MD, MPH,a and Claude Deschamps, MD,b Boston, Mass, and Rochester, MinnAtrial fibrillation is the most common cardiac arrhythmia. It
is commonly known as irregularly irregular because the
time elapsing between 2 consecutive R waves do not follow
a repetitive pattern and there are no distinct P waves.
Atrial fibrillation has significant morbidity and associ-
ated health care costs. Many medical and nonmedical treat-
ments exist to control atrial fibrillation. Catheter ablation of
atrial fibrillation foci is a relatively new technology to man-
age atrial fibrillation in selected patients.
Minimally invasive techniques in all fields of surgery and
medicine have blossomed with new technology and in-
creased patient interest. Long-term results are lacking and
new potential complications related to the new technologies
are now being seen.
Catheter-based therapies for atrial fibrillation are part of
the current guidelines recommended by major international
cardiovascular societies.1
Since the initial report by Ha€ınsaguerre and colleagues2
of pulmonary vein foci as initiators of atrial fibrillation in
1998, many developments have been made to ablate these
foci to eradicate atrial fibrillation. Long-term follow-upand potential complications from many of these advanced
techniques are unknown.
Circumferential pulmonary vein and left atrial ablation is
reported to be effective for paroxysmal and chronic atrial fi-
brillation.3-5 In the 2011 focused update on the management
of patients with atrial fibrillation, the American College of
Cardiology, American Heart Association, and the European
Society of Cardiology continue to recommend ablation
therapies to manage atrial fibrillation.1
The technique for catheter ablation varies by institution
and among electrophysiologists. Commonly, the proce-
dure is performed using transesophageal echocardiogram
to rule out the presence of atrial thrombi and assess ven-
tricular and valvular function. An electrode catheter in the
coronary sinus is used to record left atrial electrical activ-
ity as well as for pacing. After transseptal puncture, pa-
tients are anticoagulated with the aim to maintain an
activated clotting time of 300 seconds or greater. Different
devices exist to create lesions around the pulmonary
veins, usually 1 to 2 cm from their ostia, along the poste-
rior left atrium or roof and along the mitral isthmus.6
Catheter ablation for atrial fibrillation has a reported mor-
bidity of approximately 6%.7
Major complications after catheter ablation for atrial fibril-
lation have been reported in the cardiology, radiology, and
surgical literature.8-12 Factors identified as risk factors for
complications include multiple transseptal punctures,
prolonged and complicated sheath, catheter manipulations,
and aggressive attempts at transmural ablation (high energy
and high contact forces). The most common complication
reported are pulmonary vein stenosis (1.63%), pericardialardiovascular Surgery c Volume 145, Number 1 e9
FIGURE 1. Gastrografin esophagogram showing a contained leak
(arrow).
Case Reportstamponade (1.22%), neurologic complications (eg, stroke
and transient ischemic attack) (0.94%), esophageal injury
(ie, atrioesophageal fistula) (<0.25%), and phrenic nerve
injury (0.11%).13CLINICAL SUMMARY
A 71-year-old man with a significant past medical history
for paroxysmal atrial fibrillation, hypertension, dyslipide-
mia, and obstructive sleep apnea recently underwent radio
frequency ablation around the pulmonary veins to treat atrial
fibrillation at an outside hospital. He was prescribed the
anticoagulant warfarin and discharged from the hospital
the day after his procedure. Five days after discharge he re-
turned with a large right groin hematoma that was managed
conservatively; pseudoaneurysm was ruled out. Two weeks
later, after eating breakfast, he experienced excruciating
chest and back pain radiating to his left shoulder. He pre-
sented to his local emergency department where he was
diagnosedwith hypotension and tachycardia. His evaluation
included a chest x-ray film and a computed tomography scane10 The Journal of Thoracic and Cardiovascular Surgof his chest showing pneumopericardium and pneumome-
diastinum with oral contrast extravasation from his esopha-
gus to his pericardium. Hewas admitted to the intensive care
unit where he required vasopressor agents; a pericardial
drain was placed yielding>400 mL viscous yellow aspirate
that was positive for Gram positive rods with immediate re-
lief of his tamponade physiology. His leukocyte count was
8.1 th/cmm, hemoglobin 10.9 gm/dL, and platelets 309 th/
cumm. He was placed on broad-spectrum antibiotics and
was transferred to our institution for definite management.
On our initial assessment he was afebrile, tachycardic to
100 bpm in sinus rhythm, with blood oxygen saturation
94% on 4 L nasal cannula. He appeared to be anxious
and uncomfortable but in no acute distress. Physical exam-
ination showed that he had bilateral breath sounds clear to
auscultation and mediastinal dullness. He was warm and
well perfused without taking any vasopressor agents. A re-
peat esophagogram performed at our institution showed
a focal contained leak to the left of the distal esophagus
10 to 14 cm proximal of the esophagogastric junction
(Figure 1).
Lower extremity duplex ruled out deep vein thrombosis
and a bedside echocardiogram ruled out air within the left
atrium. A subsequent esophagoduodenoscopy was per-
formed by one of our advance endoscopists. Minimal insuf-
flation revealed a small, 2- to 3-mm thermal burn 35 cm
from the incisors without evidence of a fistulous tract. A
fully covered self-expandable metal stent (SEMS) (proxi-
mal and distal flanges 28 and 23 mm) was placed over
a wire and under direct visualization.
A subsequent chest x-ray film showed stent migration
for which another endoscopy was performed and the fully
covered SEMS was removed and a partially covered
SEMS was placed (Ultraflex esophageal stent; Boston Sci-
entific, Natick, Mass) (28/23 mm diameter, 12 cm long,
9 mm covered).
During recovery the patient was diagnosed with acalcu-
lous cholecystitis by ultrasound and computed tomography
scan. The symptoms were resolved when a percutaneous
cholecystostomy tube was placed. A new swallow study
showed a persistent leak around the esophageal stent
(Figure 2). At this point our endoscopist performed an over-
lapping stent-in-stent approach to control the leak. The
attempt was determined to be unsuccessful because the
pooled contrast seen in a swallow study refluxed around
the stent, showing evidence of a persistent leak. Both over-
lapping stents were removed and the patient was taken to
the operating room.
OPERATIVE APPROACH
In the right lateral decubitus position, a left posterolat-
eral thoracotomy though the fifth intercostal space was per-
formed. Moderate intrapleural contamination was found,
and the inferior pulmonary ligament was taken down withery c January 2013
FIGURE 2. Gastrografin esophagogram showing a contained leak around
the self-expandable metal stent (arrow).
FIGURE 3. Intraoperative photograph showing the esophageal/pericar-
dial perforation.
Case Reportselectrocautery. The esophagus was dissected cephalad from
the diaphragmatic hiatus until the fistulous communication
with the pericardiumwas identified and then beyond for an-
other 3 cm. The fistula was taken down sharply. The esoph-
ageal perforation was clearly defined, measuring 3 mm in
size (Figure 3). The pericardium was debrided and no def-
inite atrial opening was identified. The esophageal perfora-
tion was oversewn in 2 layers with nonabsorbable suture
material and an autologous pericardial patch was used to
buttress the repair. A surgical drain and a single chest
tube were placed. The patient tolerated the procedure well.
The patient’s postoperative course was unremarkable.
Postoperative swallow study on postoperative day 6
showed no evidence of leak. His diet was advanced
and he was discharged from the hospital on postoperative
day 12.DISCUSSION
Esophageal injuries after catheter ablation for atrial
fibrillation are rare, with the exact incidence ranging from
0.05% to 1.5%.14-16 The first case report found in the
international literature appeared in 2001.17 Since then a total
of 50 case reports, mostly single cases, were found during
our literature search (Table 1).5,7,9,11,14-32 The more
common presenting symptoms are fever, chills, chest pain,
hypotension, and transient or permanent neurologic events.
Typically, an emergency medicine physician initially
evaluates the patient. Computed tomography scans, swal-
low studies, and echocardiograms are commonly obtained
during initial evaluation. Signs of unusual chest pain, sepsis,The Journal of Thoracic and Catamponade, pneumopericardium, or transient ischemic at-
tacks in patients with a recent history of catheter ablation
therapy should alert physicians to act promptly, involving
the radiologists, cardiologists, and cardiothoracic surgeons
because early aggressive intervention is the only factor that
influences survival.16,26,33
Endoscopic therapies to evaluate the esophagus or to at-
tempt stenting should be used with extreme caution and not
until an atrioesophageal communication has been ruled out,
because this can have lethal consequences due to the fact
that carbon dioxide insufflation can cause irreversible mas-
sive air embolization.
In our patient, an atrial communication was ruled out
clinically and by computed tomography scan, esophago-
gram, and echocardiogram; hence, the possibility to attempt
endoluminal therapy. This proved to be inadequate initially
due to stent migration. Despite adequate apposition of the
stent, there was a persistent leak around the distal end. At
that point surgery became the best therapeutic option for
this patient.
Esophageal stents were used in 3 other patients reported
in the literature,9,26,33 and that approach was successful
in 2 patients.26,33 The timing of presentation of
esophagopericardial fistula varies, ranging from 3 to 50
days with a mean of 19 days from the ablation therapy.
Based on our literature review, we determined the most
frequent presentation is a left atrioesophageal fistula, but
pure esophagopericardial fistulae are also described.
Sequelae from this complication are potentially severe and
include transient or permanent neurologic events due to air
embolism, sepsis, shock, and death if left untreated.7,23,33
Based on the literature, 88% of patients present or de-
velop some form of neurologic event secondary to air embo-
lism during their hospitalization that results in death in
some cases10-12 (Table 1). Operative approaches used in
the described cases ranged from median sternotomies to
right or left thoracotomies. In our patient the swallow studyrdiovascular Surgery c Volume 145, Number 1 e11
TABLE 1. Literature review of esophageal complications from ablation therapy for atrial fibrillation
Author Year
No. of
cases Type
Timing of
presentation
Cerebral
embolism Stent Operation Result
Scanavacca, M15 2007 1 AEF 3 weeks þ   Death
Pappone, C18 2004 2 AEF 3 days, 3 weeks þ   Embolic stroke, death
Cummings, J19 2006 9 AEF 10-16 days þ (8/9)   Death (9)
Schley, P20 2006 1 AEF 26 days þ   Death
Grubina, R21 2009 1 PEF 15 days   þ Left thoracotomy, suture repair Discharge on POD 11
Cazavet, A9 2010 1 AEF 38 days þ þ failed þ Left thoracotomy, suture repair,
pericardial patch
Discharge on POD 37
Gillinov, M17 2001 1 (i) AEF 9 days þ  Right thoracotomy, CPB Death
Warren, S22 2007 1 AEF 25 days þ  þ Death
Sonmez, B23 2003 1 (i) AEF 22 days þ  þ Death
Mohr, FW5 2002 3 (i) AEF 3-9 days þ  þ Death 1/3
Preis, O24 2007 1 AEF 38 days þ  þ Discharge on POD 56
Ouchikhe, A25 2008 1 AEF 21 days þ   Death
Hazell, W26 2009 1 AEF 23 days þ þ  Death
Malamis, AP27 2007 1 AEF 5 weeks   þ Death
Doll, N16 2003 4 AEF 6-12 days 2/4  þ 4/4 Death 1/4
Borchert, B28 2008 1 AEF 13 days þ  þ Death
French, KF11 2011 1 AEF 50 days þ   Death
Gilcrease, GW29 2010 1 AEF 10 days þ   Death
Siegel, MO30 2010 1 AEF 14 days þ  þ Survival
Kandhar, S31 2010 1 AEF 27 days þ  þ Survival
Ghia, KK32 2009 6 AEF NA þ  NA Death 5/6
Dagres, N14 2006 5 (4i) AEF 8-28 days 3/5  3/5 Death 2/5
Cappato, R7 2009 5 AEF 10-16 days NA NA NA Death 5/5
AEF, Atrioesophageal fistula; PEF, pericardio-esophageal fistula; CPB, cardiopulmonary bypass; (i), intraoperative ablation; NA, not applicable; POD, postoperative day.
Case Reportsshowed a left-sided leak with a moderate left pleural effu-
sion. This is why we chose a left-side surgical approach.
In patients with atrioesophageal fistula it is important to
be prepared to apply cardiopulmonary bypass if needed.
Most of the time the esophagus can be repaired without
the need for esophageal resection. Tissue interposition
(eg, muscle, pericardium, and pleura) has been advocated
by most authors for managing atrioesophageal fistulae as
well as for managing esophageal perforations.9,14,15,34,35
Mortality has been reported between 75% and 83%,7
with many survivors remaining with neurologic sequelae.
Probably there are other patients who die after catheter
ablation therapy for atrial fibrillation without a known
cause, maybe due to massive air embolism from an un-
diagnosed atrioesophageal fistula, making the real mor-
tality unknown. The mechanism of fistula formation
during ablation is not completely understood, because le-
sions, temperature, contact duration, and devices vary.
The esophagus lies directly behind the left atrium and
it is conceivable that thermal energy from the radiofre-
quency ablation can transmit through the atrial wall
into the esophageal tissues. It has been hypothesized
that reflux and acid contact with already injured esopha-
geal mucosa leads to perforation and fistula.
Many reports from the electrophysiology literature rec-
ognize this potential complication and new techniquese12 The Journal of Thoracic and Cardiovascular Surgand maneuvers to minimize its occurrence have been
reported,4,36 including esophageal temperature probes,
endoscopic displacement of the esophagus during
ablation,37 pre- and post-treatment with proton pump inhib-
itors, and aggressive correction of dehydration in attempt to
ensure adequate esophageal blood flow for the theoretical
heat sink effect benefit.CONCLUSIONS
Increasing numbers of catheter-based ablation therapies
will be performed in the future for atrial fibrillation. It is
important that physicians are familiar with its potential
complications. Atrioesophageal and pericardioesophageal
fistulae are rare events but carry high morbidity and mortal-
ity. Early recognition and aggressive multidisciplinary sur-
gical management are the only factors that can affect
survival of an otherwise lethal complication.References
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